Notable Analyst Rating Changes 09/17: VITA, ORCL, CTL, OSK Upgraded; ARNA, MELI, ARRS, SPN Downgraded
Tweet Send to a Friend
UPGRADES
Lazard Capital upgrades Orthovita Inc. (Nasdaq: VITA) from Hold to Buy, with a price target of $4.
JMP ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Lazard Capital upgrades Orthovita Inc. (Nasdaq: VITA) from Hold to Buy, with a price target of $4.
JMP ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
